Utah Medical Products (UTMD) Stock Price, News & Analysis

Company Overview

Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO, an umbilical vessel catheters, including DIALY-NATE disposable peritoneal dialysis sets; PALA-NATE silicone oral protection devices; URI-CATH urinary drainage systems; NUTRI-CATH\NUTRI-LOK feeding device; PICC-NATE, a percutaneous intraepithelial central venous catheter; MYELO-NATE lumbar sampling kits; HEMO-NATE disposable filters; and catheterization procedure tray of instruments and supplies. In addition, the company offers LETZ system to excise cervical intraepithelial neoplasia and other lower genital tract lesions; loop, ball, and needle electrodes; FILTRESSE evacuators; other specialty electrodes and supplies, and gynecologic tools; Femcare trocars, cannulae, laparoscopic instruments, and accessories; and EPITOME and OptiMicro electrosurgical devices. Further, it provides Filshie Clip female surgical contraception devices; PATHFINDER PLUS, an endoscopic irrigation devices; suprapubic catheterization; LIBERTY, an urinary incontinence treatment and control systems; ENDOCURETTE, a curette for uterine endometrial tissue sampling; TVUS/HSG-Cath to assess abnormal or dysfunctional uterine bleeding and other abnormalities of uterus; and LUMIN, a tool to manipulate the uterus in laparoscopic procedures. Additionally, it offers DELTRAN, a disposable pressure transducer; high-pressure and piezo-resistive transducer assemblies; and pressure monitoring accessories, components, and other molded parts. It serves neonatal intensive care units, labor and delivery departments, women's health centers in hospitals, outpatient clinics, and physician's offices. The company was incorporated in 1978 and is headquartered in Midvale, Utah.

Key Stats

• Today's Range: $55.87 to $57.99
• 50-Day Range: $51.75 to $57.80
• 52-Week Range: $51.26 to $77.33
• Volume: 51,734 shs
• Average Volume: 19,522 shs
• Market Capitalization: $187.85 million
• P/E Ratio: 15.29
• Dividend Yield: 2.11%
• Price Target: N/A
• Consensus Rating: N/A

Utah Medical Products Stock Analysis - MarketRank™

Utah Medical Products scored higher than 48% of companies evaluated by MarketBeat, and ranked 617th out of 940 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: N/A
• Analyst Rating: N/A

Consensus Rating

There is not enough analysis data for Utah Medical Products.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Utah Medical Products is 15.29, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.00.

Price to Earnings Ratio vs. Sector

The P/E ratio of Utah Medical Products is 15.29, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 26.15.

Price to Book Value per Share Ratio

Utah Medical Products has a P/B Ratio of 1.67. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 2.0 / 5
• Short Interest Level: Bearish

Percentage of Shares Shorted

3.15% of the float of Utah Medical Products has been sold short.

Short Interest Ratio / Days to Cover

Utah Medical Products has a short interest ratio ("days to cover") of 5.7.

Change versus previous month

Short interest in Utah Medical Products has recently increased by 2.70%, indicating that investor sentiment is decreasing.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

Utah Medical Products pays a meaningful dividend of 2.11%, higher than the bottom 25% of all stocks that pay dividends.

Dividend Growth

Utah Medical Products has only been increasing its dividend for 3 years.

Dividend Coverage

The dividend payout ratio of Utah Medical Products is 32.28%. This payout ratio is at a healthy, sustainable level, below 75%.

Sustainability and ESG

• Score: 4.1 / 5
• Environmental Score: -1.05

Percentage of Shares Shorted

3.15% of the float of Utah Medical Products has been sold short.

Short Interest Ratio / Days to Cover

Utah Medical Products has a short interest ratio ("days to cover") of 5.7.

Change versus previous month

Short interest in Utah Medical Products has recently increased by 2.70%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 2.2 / 5
• News Sentiment: 1.01

News Sentiment

Utah Medical Products has a news sentiment score of 1.01. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.

News Coverage This Week

MarketBeat has tracked 3 news articles for Utah Medical Products this week, compared to 1 article on an average week.

Search Interest

Only 1 people have searched for UTMD on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.

Company Ownership

• Score: 1.7 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Utah Medical Products insiders have not sold or bought any company stock.

Percentage Held by Insiders

Only 7.40% of the stock of Utah Medical Products is held by insiders.

Percentage Held by Institutions

69.60% of the stock of Utah Medical Products is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

UTMD Stock Analysis - Frequently Asked Questions

How have UTMD shares performed this year?

Utah Medical Products' stock was trading at $61.47 at the beginning of the year. Since then, UTMD shares have decreased by 6.0% and is now trading at $57.80.
View the best growth stocks for 2025 here.

How were Utah Medical Products' earnings last quarter?

Utah Medical Products, Inc. (NASDAQ:UTMD) announced its quarterly earnings results on Tuesday, April, 29th. The medical instruments supplier reported $0.92 EPS for the quarter. The medical instruments supplier had revenue of $9.71 million for the quarter. Utah Medical Products had a net margin of 33.00% and a trailing twelve-month return on equity of 10.74%.

How do I buy shares of Utah Medical Products?

Shares of UTMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Utah Medical Products own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Utah Medical Products investors own include American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), DiamondRock Hospitality (DRH), iShares Micro-Cap ETF (IWC) and AU Optronics (AUOTY).

Company Calendar

• Record date for 4/3 Dividend: 3/14/2025
• Ex-Dividend for 4/3 Dividend: 3/14/2025
• Dividend Payable: 4/03/2025
• Last Earnings: 4/29/2025
• Record date for 7/3 Dividend: 6/16/2025
• Ex-Dividend for 7/3 Dividend: 6/16/2025
• Today: 6/29/2025
• Dividend Payable: 7/03/2025
• Next Earnings (Estimated): 7/24/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Health Care Supplies
• Current Symbol: NASDAQ:UTMD
• CIK: 706698
• Web: www.utahmed.com
• Phone: (801) 566-1200
• Fax: 801-566-7305
• Employees: 180
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): $3.78
• Trailing P/E Ratio: 15.29
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $13.87 million
• Net Margins: 33.00%
• Pretax Margin: 40.39%
• Return on Equity: 10.74%
• Return on Assets: 10.27%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 22.29
• Quick Ratio: 20.29

Sales & Book Value

• Annual Sales: $40.90 million
• Price / Sales: 4.59
• Cash Flow: $4.93 per share
• Price / Cash Flow: 11.72
• Book Value: $34.62 per share
• Price / Book: 1.67

Miscellaneous

• Outstanding Shares: 3,250,000
• Free Float: 3,008,000
• Market Cap: $187.85 million
• Optionable: Not Optionable
• Beta: 0.27